At a Glance
| 1cP-AL-LAD | MiPLA | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 100–225 µg | 150–200 µg |
| Total Duration | 3.3–7 hrs | 2.1–4.2 hrs |
| Routes | oral | oral |
| Effects | 72 documented | 67 documented |
Dosage
oral
| Level | 1cP-AL-LAD | MiPLA |
|---|---|---|
| Threshold | 20 µg | 50 µg |
| Light | 50–100 µg | 100–150 µg |
| Common | 100–225 µg | 150–200 µg |
| Strong | 225–350 µg | 200–250 µg |
| Heavy | 350 µg | 300 µg |
Duration
oral
1cP-AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up30 min – 1 hrs
Peak2.5 hrs – 5 hrs
Effects
Safety
Interaction: 1cP-AL-LAD + MiPLA
No direct interaction data available between these substances. This does not mean the combination is safe.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
MiPLA — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1cP-AL-LAD and MiPLA?
1cP-AL-LAD is classified as a Psychedelic (Lysergamides) while MiPLA is classified as a Psychedelic (Lysergamides). They share 66 effects in common, with 6 effects unique to 1cP-AL-LAD and 1 unique to MiPLA.
Is it safe to combine 1cP-AL-LAD and MiPLA?
There is no direct interaction data available for combining 1cP-AL-LAD and MiPLA. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1cP-AL-LAD or MiPLA?
At common doses via oral, 1cP-AL-LAD is typically dosed at 100–225 µg while MiPLA is dosed at 150–200 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.